AI Startup Latest Funding Deal: Cohere raised $500M Series D round

Artificial Intelligence | Machine Learning | Machine Perception ArsenalBio | Cell Therapy Company

Enterprise, Biotechnology, Cancer Immunology, Cell Therapy South San Francisco, California, United States

Artificial Intelligence | Machine Learning | Machine Perception

ArsenalBio | Cell Therapy Company

Biotechnology, Cancer Immunology, Cell Therapy

South San Francisco, California, United States

ArsenalBio is a privately held, programmable cell therapy company focused on the realization of solid tumor cell therapy to defeat cancer. Our discovery engine comprises precise CRISPR-enabled genome editing, integrated circuits incorporating logic gates for improved tumor targeting, and therapeutic enhancements enabling multiple pharmaceutical functions. With our programmable and computationally driven approach, we aim for enhanced and broader efficacy, increased patient safety, reduced provider costs and expanded market access. Our team is engineering living medicines to attack cancer’s inherent multi-faceted nature and bring dramatic improvements to the lives of patients.

Total Funding: $305M

Funding Stage: Series B

Business Stage: Scaling Up

Market: B2B

Company Size: 101 to 250

Founded: 2019

Jan 2022

Partnership: ArsenalBio Collaborated with Bristol Myers Squibb

AI Startups Funding Deals IntelligenceTry for Free

Date

Round

$ Raised

Investors

09/06/2022

Series B

$220M

Softbank Vision Fund 2, Bristol-Myers Squibb Company, Byers Capital, Emerson Collective Investments, Green Sands, Hitachi Ventures, Sixth Street

Date : 09/06/2022

Round: Series B

$ Raised: $220M

Investors: Softbank Vision Fund 2, Bristol-Myers Squibb Company, Byers Capital, Emerson Collective Investments, Green Sands, Hitachi Ventures, Sixth Street

For AI Startup Founders

Get introduced to VC/PE/CVC investors

Get Started

For Investors at VC/PE firms

Get introduced to AI Startup founders or founders at ArsenalBio